Malini Harigopal's Biography

• Home
• |
• Register
• |
• Submissions
• |
• Posters
• |
• Agenda
• |
• Exhibition
• |
• Venue
• |
• Short Courses
  • Training Courses
• |
• Media
• |

The Role Of The Pathologist In The Measurement Of Circulating Tumor Cells (CTCs): A Pathologist’s Perspective

Tuesday, 17 November 2015 at 13:30

Add to Calendar ▼2015-11-16 00:00:002015-11-16 01:00:00Europe/LondonThe Role Of The Pathologist In The Measurement Of Circulating Tumor Cells (CTCs): A Pathologist’s PerspectiveSELECTBIOenquiries@selectbiosciences.com

The use of Circulating Tumor Cells (CTCs) is a rapidly growing new diagnostic test to help manage oncology patients. The test is being done at different institutions, even though it requires morphologic skills highly similar to those of the cytopathologist. The dramatic reduction in Pap smear specimens due to molecular technologies leaves potential capacity in the cytopathology lab. Thus, CTC analysis is an ideal new test to introduce into the cytopathology practice. After many years of basic research for assessment of circulating tumor cells (CTCs), there is now an FDA approved method available for use in clinical labs. The CellSearch System (Veridex) requires morphology skills highly similar to those of the cytopathologist to enumerate CTCs. The cytopathology lab is a natural location for this technology in the healthcare delivery system. The cytotechnologist under the supervision of the pathologist is involved in the final interpretation and enumeration of CTC. Molecular characterization of CTC provides additional prognostic information.